Filing Flows › Bio Key International (BKYI) › Q2 2026 › vs Q2 2025
Bio Key International (BKYI) Q2 2026 vs Q2 2025 (year over year)
Bio Key International's revenue rose $223K (+13%) from $1.7M in Q2 2025 to $1.9M in Q2 2026. The biggest changes: License +$423K (+53%); Hardware −$109K (-19%); Service −$91K (-28%).
Bio Key International, Q2 2026: revenue $1.9M (+13% year over year), operating margin -27.6%, net loss $577K, operating cash flow −$846K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| License | $1.2M | $806K | $423K | +53% |
| Hardware | $460K | $569K | −$109K | -19% |
| Service | $231K | $322K | −$91K | -28% |
| Revenue | $1.9M | $1.7M | $223K | +13% |
| Net loss | $577K | $1.2M | −$591K | -51% |
| Costs & expenses | $2.5M | $2.9M | −$367K | -13% |
| Operating costs | $2.4M | $2.8M | −$331K | -12% |
| Interest & other, net | $47K | $84K | −$36K | -43% |
| Cost of revenue | $246K | $464K | −$218K | -47% |
| Research & development | $640K | $636K | $4K | +0.7% |
| SG&A | $1.6M | $1.7M | −$118K | -7% |
| Operating cash sources | $963K | $1.0M | −$40K | -4% |
| Depreciation & amortization | $74K | $100K | −$26K | -26% |
| Share-based compensation | $43K | $22K | $21K | +95% |
| Cash used in operations | $846K | $880K | −$34K | -4% |
| Net loss absorbed | $577K | $1.2M | −$591K | -51% |
| Working capital & other | $386K | −$165K | $551K | — |
Questions
How much did Bio Key International's revenue grow year over year in Q2 2026?
Bio Key International's revenue rose $223K (+13%) from $1.7M in Q2 2025 to $1.9M in Q2 2026.
What drove Bio Key International's revenue change in Q2 2026?
License +$423K (+53%); Hardware −$109K (-19%); Service −$91K (-28%).